In Vivo Selection of Transplanted Hepatocytes by Pharmacological Inhibition of Fumarylacetoacetate Hydrolase in Wild-type Mice
Open Access
- 1 October 2012
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 20 (10) , 1981-1987
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Sustained correction of OTC deficiency in spfash mice using optimized self-complementary AAV2/8 vectorsGene Therapy, 2011
- Adeno‐associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo†‡Hepatology, 2010
- Testing significance relative to a fold-change threshold is a TREATBioinformatics, 2009
- Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation†Hepatology, 2008
- Gene Therapy Using Adeno-Associated Virus VectorsClinical Microbiology Reviews, 2008
- Human acute leukemia cells injected in NOD/LtSz‐scid/IL‐2Rγ null mice generate a faster and more efficient disease compared to other NOD/scid‐related strainsInternational Journal of Cancer, 2008
- Loss of p21 Permits Carcinogenesis from Chronically Damaged Liver and Kidney Epithelial Cells despite Unchecked ApoptosisCancer Cell, 2008
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007
- Slow-onset inhibition of fumarylacetoacetate hydrolase by phosphinate mimics of the tetrahedral intermediate: kinetics, crystal structure and pharmacokineticsBiochemical Journal, 2007
- A Direct Approach to False Discovery RatesJournal of the Royal Statistical Society Series B: Statistical Methodology, 2002